CompletedNot Applicable

Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)

France20 participantsStarted 2006-03

Plain-language summary

The aim of this study is to improve the diagnostic of Lewy body dementia by combining the scintigraphy (SPECT) usig a spécific transporter and magnetic resonance imaging (MRI).

Who can participate

Age range65 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with alzheimer disease following NINCDS-ADRDA scale or Lewy body dementia following Mc Keith scale. * Aged between 65 et 90 years * Patients with visual hallucination * Patients with helping people * Patients with MMSE (Mini Mental State Examination) equal or more than 18. * Signed consent Exclusion Criteria: * Hospitalized patients without their consent * Patients who have not passed the neuropsychological tests * Patients with a MMSE less than 18 * Patients without helping * Patients with no visual hallucinations * Patients with severe somatic pathology. * Pregnancy * Allergy to iodine

What they're measuring

SPECT and MRI differential imaging

Timeframe: Visit 1

Trial details

NCT IDNCT00820937

SponsorUniversity Hospital, Limoges

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-03

View on ClinicalTrials.gov More Lewy Body Dementia trials